Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Arrhythmias

Free Subscription Articles published in PLoS One Retrieve available abstracts of 173 articles: HTML format

Single Articles

January 2023
1. YUAN M, Lian H, Li P
   Spatiotemporal patterns of early afterdepolarizations underlying abnormal T-wave morphologies in a tissue model of the Purkinje-ventricular system.
   PLoS One. 2023;18:e0280267.
   PubMed     Abstract available
   
   
   
2. LEE K, Lee SK, Lee J, Jeon BK, et al
   Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.
   PLoS One. 2023;18:e0280359.
   PubMed     Abstract available
   
   
   
3. KAMALI R, Kwan E, Regouski M, Bunch TJ, et al
   Contribution of atrial myofiber architecture to atrial fibrillation.
   PLoS One. 2023;18:e0279974.
   PubMed     Abstract available
   
   
   
4. KIM SK, Park JO, Park HA, Lee CA, et al
   Analyzing willingness for extracorporeal cardiopulmonary resuscitation in refractory ventricular fibrillation.
   PLoS One. 2023;18:e0281092.
   PubMed     Abstract available
   
   
   
5. SUZUKI S, Yamashita T, Akao M, Atarashi H, et al
   Clinical phenotypes of older adults with non-valvular atrial fibrillation not treated with oral anticoagulants by hierarchical cluster analysis in the ANAFIE Registry.
   PLoS One. 2023;18:e0280753.
   PubMed     Abstract available
   
   
   
6. AURELIUS T, Ken-Dror G, Sharma SD, Amlani S, et al
   Atrial fibrillation in UK South Asian hospitalized ischemic stroke patients: The BRAINS study.
   PLoS One. 2023;18:e0281014.
   PubMed     Abstract available
   
   
   
7. WEI M, Wang P, Zhu X, Morishima M, et al
   Electrophysiological evaluation of an anticancer drug gemcitabine on cardiotoxicity revealing down-regulation and modification of the activation gating properties in the human rapid delayed rectifier potassium channel.
   PLoS One. 2023;18:e0280656.
   PubMed     Abstract available
   
   
   
8. HERNANDEZ I, He M, Guo J, Tadrous M, et al
   COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data.
   PLoS One. 2023;18:e0281068.
   PubMed     Abstract available
   
   
   
9. PONG T, Aparicio-Valenzuela J, Obafemi O, Cyr K, et al
   High-resolution spatiotemporal changes in dominant frequency and structural organization during persistent atrial fibrillation.
   PLoS One. 2023;18:e0271846.
   PubMed     Abstract available
   
   
   
10. YORIKAWA F, Ishikawa J, Tamura Y, Murao Y, et al
    Determinants of depressive symptoms in older outpatients with cardiometabolic diseases in a Japanese frailty clinic: Importance of bidirectional association between depression and frailty.
    PLoS One. 2023;18:e0281465.
    PubMed     Abstract available
    
    
    
11. GONZALEZ-MARTIN P, Sacco F, Butakoff C, Doste R, et al
    Ventricular anatomical complexity and sex differences impact predictions from electrophysiological computational models.
    PLoS One. 2023;18:e0263639.
    PubMed     Abstract available
    
    
    
12. KRITTAYAPHONG R, Boonyapiphat T, Aroonsiriwattana S, Ngamjanyaporn P, et al
    Causes of death of patients with non-valvular atrial fibrillation in Asians.
    PLoS One. 2023;18:e0282455.
    PubMed     Abstract available
    
    
    
13. MACHINO T, Aonuma K, Maruo K, Komatsu Y, et al
    Randomized crossover trial of 2-week Garment electrocardiogram with dry textile electrode to reveal instances of post-ablation recurrence of atrial fibrillation underdiagnosed during 24-hour Holter monitoring.
    PLoS One. 2023;18:e0281818.
    PubMed     Abstract available
    
    
    
14. MORET C, Acosta-Isaac R, Mojal S, Corrochano M, et al
    Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data.
    PLoS One. 2023;18:e0279297.
    PubMed     Abstract available
    
    
    
15. CLEMENS DJ, Ye D, Zhou W, Kim CSJ, et al
    SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19.
    PLoS One. 2023;18:e0282151.
    PubMed     Abstract available
    
    
    
16. GLEVA MJ, Sullivan J, Crawford TC, Walcott G, et al
    Defibrillation effectiveness and safety of the shock waveform used in a contemporary wearable cardioverter defibrillator: Results from animal and human studies.
    PLoS One. 2023;18:e0281340.
    PubMed     Abstract available
    
    
    January 2022
17. FU F, Pietropaolo M, Cui L, Pandit S, et al
    Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models.
    PLoS One. 2022;17:e0256512.
    PubMed     Abstract available
    
    
    
18. MOL D, Boersma AM, Berger WR, Khan M, et al
    Intermediate-term outcome of cryoballoon ablation of persistent atrial fibrillation and improvements in quality of life of patients.
    PLoS One. 2022;17:e0261841.
    PubMed     Abstract available
    
    
    
19. CHRISTERSSON C, Held C, Modica A, Westerbergh J, et al
    Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study.
    PLoS One. 2022;17:e0262580.
    PubMed     Abstract available
    
    
    
20. REINHART JM, de Oliveira GAR, Forsythe L, Li Z, et al
    Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.
    PLoS One. 2022;17:e0262336.
    PubMed     Abstract available
    
    
    
21. FASTNER C, Szabo K, Samartzi M, Kruska M, et al
    Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units.
    PLoS One. 2022;17:e0264122.
    PubMed     Abstract available
    
    
    
22. CHOI BJ, Koo Y, Kim TY, Lim HS, et al
    Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data.
    PLoS One. 2022;17:e0263117.
    PubMed     Abstract available
    
    
    
23. LIU X, Liu H, Wang L, Zhang L, et al
    Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0263131.
    PubMed     Abstract available
    
    
    
24. CIMINATA G, Geue C, Wu O, Deidda M, et al
    Propensity score methods for comparative-effectiveness analysis: A case study of direct oral anticoagulants in the atrial fibrillation population.
    PLoS One. 2022;17:e0262293.
    PubMed     Abstract available
    
    
    
25. NATHANIA J, Woo BFY, Cher BP, Toh KY, et al
    Patient perspectives of the Self-management and Educational Technology tool for Atrial Fibrillation (SETAF): A mixed-methods study in Singapore.
    PLoS One. 2022;17:e0262033.
    PubMed     Abstract available
    
    
    
26. SONG J, Zhang Q, Ye L, Zheng Y, et al
    The comparison of catheter ablation on hard outcomes versus medical treatment for atrial fibrillation patients: A meta-analysis of randomized, controlled trials with trial sequential analysis.
    PLoS One. 2022;17:e0262702.
    PubMed     Abstract available
    
    
    
27. MUNIR MB, Hlavacek P, Keshishian A, Guo JD, et al
    Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
    PLoS One. 2022;17:e0263903.
    PubMed     Abstract available
    
    
    
28. MARTINEZ-CAMPELO L, Cruz R, Blanco-Verea A, Moscoso I, et al
    Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome.
    PLoS One. 2022;17:e0263469.
    PubMed     Abstract available
    
    
    
29. SHABBIR MA, Saad Shaukat MH, Ehtesham M, Murawski S, et al
    Bifascicular block in unexplained syncope is underrecognized and under-evaluated: A single-center audit of ESC guidelines adherence.
    PLoS One. 2022;17:e0263727.
    PubMed     Abstract available
    
    
    
30. NASIMI F, Yazdchi M
    LDIAED: A lightweight deep learning algorithm implementable on automated external defibrillators.
    PLoS One. 2022;17:e0264405.
    PubMed     Abstract available
    
    
    
31. RUSS D, Williams JA, Cardoso VR, Bravo-Merodio L, et al
    Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models.
    PLoS One. 2022;17:e0263390.
    PubMed     Abstract available
    
    
    
32. PARK J, Jung JH, Choi EK, Lee SW, et al
    Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    PLoS One. 2022;17:e0264538.
    PubMed     Abstract available
    
    
    
33. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
    Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
    PLoS One. 2022;17:e0266939.
    PubMed     Abstract available
    
    
    
34. OCAK G, Khairoun M, Khairoun O, Bos WJW, et al
    Chronic kidney disease and atrial fibrillation: A dangerous combination.
    PLoS One. 2022;17:e0266046.
    PubMed     Abstract available
    
    
    
35. HIROSHI I, Natsuko SY, Yutaka I, Masayori S, et al
    Frequency of hemorrhage after tooth extraction in patients treated with a direct oral anticoagulant: A multicenter cross-sectional study.
    PLoS One. 2022;17:e0266011.
    PubMed     Abstract available
    
    
    
36. MATSUNAGA-LEE Y, Egami Y, Matsumoto S, Masunaga N, et al
    Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique.
    PLoS One. 2022;17:e0263938.
    PubMed     Abstract available
    
    
    
37. KOGE J, Yamagami H, Toyoda K, Yasaka M, et al
    Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.
    PLoS One. 2022;17:e0264760.
    PubMed     Abstract available
    
    
    
38. ESCOBAR CERVANTES C, Marti-Almor J, Cabeza AIP, Bowrin K, et al
    Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.
    PLoS One. 2022;17:e0266658.
    PubMed     Abstract available
    
    
    
39. NAKAI M, Iwanaga Y, Sumita Y, Wada S, et al
    Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset.
    PLoS One. 2022;17:e0264390.
    PubMed     Abstract available
    
    
    
40. SAKAMOTO K, Mukai Y, Kawai S, Nagaoka K, et al
    Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillation.
    PLoS One. 2022;17:e0264894.
    PubMed     Abstract available
    
    
    
41. UHE T, Stegmann T, Langhammer R, Dagres N, et al
    Signs of left atrial disease and 10-year risk of atrial fibrillation.
    PLoS One. 2022;17:e0266848.
    PubMed     Abstract available
    
    
    
42. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
    Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
    PLoS One. 2022;17:e0266955.
    PubMed     Abstract available
    
    
    
43. WEI N, Tolkacheva EG
    Mechanisms of arrhythmia termination during acute myocardial ischemia: Role of ephaptic coupling and complex geometry of border zone.
    PLoS One. 2022;17:e0264570.
    PubMed     Abstract available
    
    
    
44. ARNOLD R, Hofer E, Haas J, Sanchez-Quintana D, et al
    Diversity and complexity of the cavotricuspid isthmus in rabbits: A novel scheme for classification and geometrical transformation of anatomical structures.
    PLoS One. 2022;17:e0264625.
    PubMed     Abstract available
    
    
    
45. YAMADA Y, Minatoguchi S, Baba S, Shibata S, et al
    Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction.
    PLoS One. 2022;17:e0265347.
    PubMed     Abstract available
    
    
    
46. WATSON GM, Sutherland J, Lacey C, Bridgman PG, et al
    A randomised cross-over trial of QT response to hyperventilation-induced anxiety and diaphragmatic breathing in patients with stress cardiomyopathy and in control patients.
    PLoS One. 2022;17:e0265607.
    PubMed     Abstract available
    
    
    
47. WANG Y, Han Z, Wang Y, Yan Y, et al
    Risk factors of sitting-induced tachycardia syndrome in children and adolescents.
    PLoS One. 2022;17:e0265364.
    PubMed     Abstract available
    
    
    
48. ALONSO A, Alam AB, Kamel H, Subbian V, et al
    Epidemiology of atrial fibrillation in the All of Us Research Program.
    PLoS One. 2022;17:e0265498.
    PubMed     Abstract available
    
    
    
49. SILAND JE, Geelhoed B, Roselli C, Wang B, et al
    Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.
    PLoS One. 2022;17:e0268768.
    PubMed     Abstract available
    
    
    
50. IKEUCHI Y, Ochi H, Motoda C, Tokuyama T, et al
    Plasma MicroRNAs as noninvasive diagnostic biomarkers in patients with Brugada syndrome.
    PLoS One. 2022;17:e0261390.
    PubMed     Abstract available
    
    
    
51. SENOO K, Yukawa A, Ohkura T, Shoji K, et al
    Screening for untreated atrial fibrillation in the elderly population: A community-based study.
    PLoS One. 2022;17:e0269506.
    PubMed     Abstract available
    
    
    
52. JANG HJ, Lee D, Kim TH, Kim JS, et al
    Clinical outcomes of gastrointestinal bleeding management during anticoagulation therapy.
    PLoS One. 2022;17:e0269262.
    PubMed     Abstract available
    
    
    
53. DING M, Li QF, Yin G, Liu JL, et al
    Effects of Drosophila melanogaster regular exercise and apolipoprotein B knockdown on abnormal heart rhythm induced by a high-fat diet.
    PLoS One. 2022;17:e0262471.
    PubMed     Abstract available
    
    
    
54. SAMUEL JP, Wootton SH, Holder T, Molony D, et al
    A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes.
    PLoS One. 2022;17:e0269387.
    PubMed     Abstract available
    
    
    
55. EROGLU TE, Blom MT, Souverein PC, Yasmina A, et al
    Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.
    PLoS One. 2022;17:e0267016.
    PubMed     Abstract available
    
    
    
56. KORNEJ J, Friedrich K, Schroeter ML, Witte AV, et al
    PR interval duration is associated with the presence of white matter hyperintensities: Insights from the epidemiologic LIFE-Adult Study.
    PLoS One. 2022;17:e0269815.
    PubMed     Abstract available
    
    
    
57. MOON I, Go TH, Kim JY, Kang DR, et al
    Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.
    PLoS One. 2022;17:e0268113.
    PubMed     Abstract available
    
    
    
58. ROGERS JD, Higuera L, Rosemas SC, Cheng YJ, et al
    Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patients.
    PLoS One. 2022;17:e0270398.
    PubMed     Abstract available
    
    
    
59. FALKENBERG M, Coleman JA, Dobson S, Hickey DJ, et al
    Identifying locations susceptible to micro-anatomical reentry using a spatial network representation of atrial fibre maps.
    PLoS One. 2022;17:e0267166.
    PubMed     Abstract available
    
    
    
60. DARVISHI A, Sadeghipour P, Darrudi A, Daroudi R, et al
    Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran.
    PLoS One. 2022;17:e0270642.
    PubMed     Abstract available
    
    
    
61. FARRAG NA, Thornhill RE, Prato FS, Skanes AC, et al
    Assessment of left atrial fibrosis progression in canines following rapid ventricular pacing using 3D late gadolinium enhanced CMR images.
    PLoS One. 2022;17:e0269592.
    PubMed     Abstract available
    
    
    
62. MOKGOKONG R, Schnabel R, Witt H, Miller R, et al
    Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries.
    PLoS One. 2022;17:e0269867.
    PubMed     Abstract available
    
    
    
63. BOUWMEESTER S, van Loon T, Ploeg M, Mast TP, et al
    Left atrial remodeling in mitral regurgitation: A combined experimental-computational study.
    PLoS One. 2022;17:e0271588.
    PubMed     Abstract available
    
    
    
64. SU CH, Lo CH, Chen HH, Tsai CF, et al
    CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke.
    PLoS One. 2022;17:e0270823.
    PubMed     Abstract available
    
    
    
65. ZHU L, Marsh JW, Griffith MP, Collins K, et al
    Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
    PLoS One. 2022;17:e0271381.
    PubMed     Abstract available
    
    
    
66. KABUS D, Arno L, Leenknegt L, Panfilov AV, et al
    Numerical methods for the detection of phase defect structures in excitable media.
    PLoS One. 2022;17:e0271351.
    PubMed     Abstract available
    
    
    
67. NAKAJIMA T, Kawabata-Iwakawa R, Tamura S, Hasegawa H, et al
    Novel CACNA1C R511Q mutation, located in domain - linker, causes non-syndromic type-8 long QT syndrome.
    PLoS One. 2022;17:e0271796.
    PubMed     Abstract available
    
    
    
68. CHOI JH, Park SJ, Park KM, Kim JS, et al
    Efficacy and safety of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation: A comparison with radiofrequency ablation.
    PLoS One. 2022;17:e0265482.
    PubMed     Abstract available
    
    
    
69. DUAN J, Wang Q, Zhang B, Liu C, et al
    Accurate detection of atrial fibrillation events with R-R intervals from ECG signals.
    PLoS One. 2022;17:e0271596.
    PubMed     Abstract available
    
    
    
70. PRADELLA M, Anastasopoulos C, Yang S, Moor M, et al
    Associations between fully-automated, 3D-based functional analysis of the left atrium and classification schemes in atrial fibrillation.
    PLoS One. 2022;17:e0272011.
    PubMed     Abstract available
    
    
    
71. PALA E, Bustamante A, Clua-Espuny JL, Acosta J, et al
    Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study.
    PLoS One. 2022;17:e0273571.
    PubMed     Abstract available
    
    
    
72. AMAMI K, Yoshihisa A, Horikoshi Y, Yamada S, et al
    Utility of a novel wearable electrode embedded in an undershirt for electrocardiogram monitoring and detection of arrhythmias.
    PLoS One. 2022;17:e0273541.
    PubMed     Abstract available
    
    
    
73. ALKHALFAN F, Gyftopoulos A, Chen YJ, Williams CH, et al
    Identifying genetic variants associated with the ICD10 (International Classification of Diseases10)-based diagnosis of cerebrovascular disease using a large-scale biomedical database.
    PLoS One. 2022;17:e0273217.
    PubMed     Abstract available
    
    
    
74. DE MARCO F, Ferrucci F, Risi M, Tortora G, et al
    Classification of QRS complexes to detect Premature Ventricular Contraction using machine learning techniques.
    PLoS One. 2022;17:e0268555.
    PubMed     Abstract available
    
    
    
75. CHANG YK, Fan HC, Lin CC, Wang YH, et al
    Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus.
    PLoS One. 2022;17:e0273646.
    PubMed     Abstract available
    
    
    
76. GO MT, George AM, Tahsin B, Fogelfeld L, et al
    Tachycardia in hyperthyroidism: Not so common.
    PLoS One. 2022;17:e0273724.
    PubMed     Abstract available
    
    
    
77. DE LUSIGNAN S, Hobbs FDR, Liyanage H, Sherlock J, et al
    Long term follow up of direct oral anticoagulants and warfarin therapy on stroke, with all-cause mortality as a competing risk, in people with atrial fibrillation: Sentinel network database study.
    PLoS One. 2022;17:e0265998.
    PubMed     Abstract available
    
    
    
78. BORJESSON E, Svennblad B, Wisten A, Borjesson M, et al
    Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden.
    PLoS One. 2022;17:e0273567.
    PubMed     Abstract available
    
    
    
79. KUMAR M A, Chakrapani A
    Classification of ECG signal using FFT based improved Alexnet classifier.
    PLoS One. 2022;17:e0274225.
    PubMed     Abstract available
    
    
    
80. BEIER L, Lu S, Franca LR, Marler S, et al
    Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
    PLoS One. 2022;17:e0274237.
    PubMed     Abstract available
    
    
    
81. LIU Y, Sun XX, Du WY, Chen TT, et al
    Intensive versus conservative glycemic control in patients undergoing coronary artery bypass graft surgery: A protocol for systematic review of randomised controlled trials.
    PLoS One. 2022;17:e0276228.
    PubMed     Abstract available
    
    
    
82. CHOI SH, Kim M, Kim H, Kim DH, et al
    Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.
    PLoS One. 2022;17:e0275103.
    PubMed     Abstract available
    
    
    
83. TEPPO K, Jaakkola J, Langen VL, Biancari F, et al
    Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    PLoS One. 2022;17:e0276612.
    PubMed     Abstract available
    
    
    
84. CELIK E, Hokamp NG, Goertz L, Fehske W, et al
    Is there an association between left atrial outpouching structures and recurrence of atrial fibrillation after catheter ablation?
    PLoS One. 2022;17:e0276369.
    PubMed     Abstract available
    
    
    
85. NA SJ, Yang JH, Ko RE, Chung CR, et al
    Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
    PLoS One. 2022;17:e0277087.
    PubMed     Abstract available
    
    
    
86. TSAI HJ, Wong YS, Ong CT
    Clinical course and risk factors for sleep disturbance in patients with ischemic stroke.
    PLoS One. 2022;17:e0277309.
    PubMed     Abstract available
    
    
    
87. TAKAYA Y, Nakayama R, Yokohama F, Toh N, et al
    Left atrial appendage morphology with the progression of atrial fibrillation.
    PLoS One. 2022;17:e0278172.
    PubMed     Abstract available
    
    
    
88. WONG CK, Makalic E, Dite GS, Whiting L, et al
    Polygenic risk scores for cardiovascular diseases and type 2 diabetes.
    PLoS One. 2022;17:e0278764.
    PubMed     Abstract available
    
    
    
89. CHATTOPADHYAY RK, Chousou PA, Mukherjee T, Pugh PJ, et al
    The predictive value of abnormal P-wave axis for the detection of incident atrial fibrillation: A systematic review with meta-analysis.
    PLoS One. 2022;17:e0278527.
    PubMed     Abstract available
    
    
    
90. PERREAULT S, Cote R, Dragomir A, White-Guay B, et al
    Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation.
    PLoS One. 2022;17:e0277744.
    PubMed     Abstract available
    
    
    
91. ATZEMA CL, Stiell IG, Chong AS, Austin PC, et al
    Validating emergency department cardioversion procedures in provincial administrative data in Ontario, Canada.
    PLoS One. 2022;17:e0277598.
    PubMed     Abstract available
    
    
    
92. CORROCHANO M, Acosta-Isaac R, Plaza M, Munoz R, et al
    Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants.
    PLoS One. 2022;17:e0278693.
    PubMed     Abstract available
    
    
    
93. NAGATA Y, Watanabe R, Eichhorn C, Ohno S, et al
    Targeted deep sequencing analyses of long QT syndrome in a Japanese population.
    PLoS One. 2022;17:e0277242.
    PubMed     Abstract available
    
    
    
94. KAWAJI T, Shizuta S, Tanaka M, Nishiwaki S, et al
    Prognostic impact of catheter ablation in patients with asymptomatic atrial fibrillation.
    PLoS One. 2022;17:e0279178.
    PubMed     Abstract available
    
    
    
95. ZENG Z, Wang Q, Yu Y, Zhang Y, et al
    Assessing electrocardiogram changes after ischemic stroke with artificial intelligence.
    PLoS One. 2022;17:e0279706.
    PubMed     Abstract available
    
    
    
96. NAWAZ M, Ahmed J
    Cloud-based healthcare framework for real-time anomaly detection and classification of 1-D ECG signals.
    PLoS One. 2022;17:e0279305.
    PubMed     Abstract available
    
    
    
97. MORI M, Zogg CK, Amabile A, Fereydooni S, et al
    Impact of secondary mitral regurgitation on survival in atrial and ventricular dysfunction.
    PLoS One. 2022;17:e0277385.
    PubMed     Abstract available
    
    
    
98. TUTUKO B, Darmawahyuni A, Nurmaini S, Tondas AE, et al
    DAE-ConvBiLSTM: End-to-end learning single-lead electrocardiogram signal for heart abnormalities detection.
    PLoS One. 2022;17:e0277932.
    PubMed     Abstract available
    
    
    January 2021
99. KOOK H, Kim HD, Shim J, Kim YH, et al
    Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    PLoS One. 2021;16:e0244723.
    PubMed     Abstract available
    
    
    
100. FINGROVA Z, Ambroz D, Jansa P, Kuchar J, et al
     The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension.
     PLoS One. 2021;16:e0245752.
     PubMed     Abstract available
     
     
     
101. REZAEI-DARZI E, Mehdipour P, Di Cesare M, Farzadfar F, et al
     Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis.
     PLoS One. 2021;16:e0246253.
     PubMed     Abstract available
     
     
     
102. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
     Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
     PLoS One. 2021;16:e0255263.
     PubMed     Abstract available
     
     
     
103. SILAND JE, Nguyen BO, de With RR, Van Gelder IC, et al
     Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women.
     PLoS One. 2021;16:e0246907.
     PubMed     Abstract available
     
     
     
104. SCHMIDT MM, Griffin JM, McCabe P, Stuart-Mullen L, et al
     Shared medical appointments: Translating research into practice for patients treated with ablation therapy for atrial fibrillation.
     PLoS One. 2021;16:e0246861.
     PubMed     Abstract available
     
     
     
105. QAZI JZ, Schnitzer ME, Cote R, Martel MJ, et al
     Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
     PLoS One. 2021;16:e0246691.
     PubMed     Abstract available
     
     
     
106. XIAOKERETI J, Guo YK, Dong ZY, Ma M, et al
     Enhanced atrial internal-external neural remodeling facilitates atrial fibrillation in the chronic obstructive sleep apnea model.
     PLoS One. 2021;16:e0247308.
     PubMed     Abstract available
     
     
     
107. SHIYOVICH A, Chodick G, Azani L, Tirosh M, et al
     Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: A long-term real-world data analysis.
     PLoS One. 2021;16:e0247097.
     PubMed     Abstract available
     
     
     
108. DIMAI S, Semmler L, Prabhu A, Stachelscheid H, et al
     COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
     PLoS One. 2021;16:e0255976.
     PubMed     Abstract available
     
     
     
109. CHAU E, Rosella LC, Mondor L, Wodchis WP, et al
     Association between continuity of care and subsequent diagnosis of multimorbidity in Ontario, Canada from 2001-2015: A retrospective cohort study.
     PLoS One. 2021;16:e0245193.
     PubMed     Abstract available
     
     
     
110. MATUZ A, van der Linden D, Kisander Z, Hernadi I, et al
     Enhanced cardiac vagal tone in mental fatigue: Analysis of heart rate variability in Time-on-Task, recovery, and reactivity.
     PLoS One. 2021;16:e0238670.
     PubMed     Abstract available
     
     
     
111. CHO SS, Jo SH, Kim HJ, Lee MH, et al
     Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohort.
     PLoS One. 2021;16:e0248386.
     PubMed     Abstract available
     
     
     
112. KOZIEL M, Teutsch C, Halperin JL, Rothman KJ, et al
     Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF.
     PLoS One. 2021;16:e0249524.
     PubMed     Abstract available
     
     
     
113. LIN YC, Chen BL, Shih CM, Lin FY, et al
     Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.
     PLoS One. 2021;16:e0249940.
     PubMed     Abstract available
     
     
     
114. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
     Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
     PLoS One. 2021;16:e0247145.
     PubMed     Abstract available
     
     
     
115. WENG S, Wang B, Li M, Chao S, et al
     Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
     PLoS One. 2021;16:e0249997.
     PubMed     Abstract available
     
     
     
116. ABAD R, Collart O, Ganesan P, Rogers AJ, et al
     Three dimensional reconstruction to visualize atrial fibrillation activation patterns on curved atrial geometry.
     PLoS One. 2021;16:e0249873.
     PubMed     Abstract available
     
     
     
117. GOMES FREITAS C, Walsh M, Coutinho EL, Vincenzo de Paola AA, et al
     Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial.
     PLoS One. 2021;16:e0248567.
     PubMed     Abstract available
     
     
     
118. ALAMMARI M, Sultana K, Alturaiki A, Thomas A, et al
     The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population.
     PLoS One. 2021;16:e0250502.
     PubMed     Abstract available
     
     
     
119. RUFF C, Gerharz A, Groll A, Stoll F, et al
     Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
     PLoS One. 2021;16:e0250298.
     PubMed     Abstract available
     
     
     
120. HAIDL H, Gaugler J, Cvirn G, Jasser-Nitsche H, et al
     Impact of electric cardioversion on platelet activation.
     PLoS One. 2021;16:e0250353.
     PubMed     Abstract available
     
     
     
121. DHILLON GS, Ahluwalia N, Honarbakhsh S, Graham A, et al
     Impact of adenosine on mechanisms sustaining persistent atrial fibrillation: Analysis of contact electrograms and non-invasive ECGI mapping data.
     PLoS One. 2021;16:e0248951.
     PubMed     Abstract available
     
     
     
122. JANG S, Ogunmoroti O, Zhao D, Fashanu OE, et al
     The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
     PLoS One. 2021;16:e0248644.
     PubMed     Abstract available
     
     
     
123. RAVVAZ K, Weissert JA, Jahangir A, Ruff CT, et al
     Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation.
     PLoS One. 2021;16:e0248134.
     PubMed     Abstract available
     
     
     
124. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
     Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
     PLoS One. 2021;16:e0248289.
     PubMed     Abstract available
     
     
     
125. GARCHEVA V, Akin M, Adel J, Sanchez Martinez C, et al
     High rate of critical coronary stenosis in comatose patients with Non-ST-elevation out-of-hospital cardiac arrest (NSTE-OHCA) undergoing therapeutic hypothermia-Experience from the HAnnover COoling REgistry (HACORE).
     PLoS One. 2021;16:e0251178.
     PubMed     Abstract available
     
     
     
126. YANASE T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
     Factors associated with temporary pacing insertion in patients with inferior ST-segment elevation myocardial infarction.
     PLoS One. 2021;16:e0251124.
     PubMed     Abstract available
     
     
     
127. ZAGIDULLIN NS, Motloch LJ, Musin TI, Bagmanova ZA, et al
     J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
     PLoS One. 2021;16:e0257982.
     PubMed     Abstract available
     
     
     
128. GUO A, Smith S, Khan YM, Langabeer Ii JR, et al
     Application of a time-series deep learning model to predict cardiac dysrhythmias in electronic health records.
     PLoS One. 2021;16:e0239007.
     PubMed     Abstract available
     
     
     
129. SYOMIN F, Osepyan A, Tsaturyan A
     Computationally efficient model of myocardial electromechanics for multiscale simulations.
     PLoS One. 2021;16:e0255027.
     PubMed     Abstract available
     
     
     
130. MASJEDI M, Jungen C, Kuklik P, Alken FA, et al
     A novel algorithm for 3-D visualization of electrogram duration for substrate-mapping in patients with ischemic heart disease and ventricular tachycardia.
     PLoS One. 2021;16:e0254683.
     PubMed     Abstract available
     
     
     
131. REICHMANN-ARIEL D, Sadeh R, Galante O, Almog Y, et al
     Central venous catheter insertion- guidewire migration ratio: Right heart to inferior vena cava.
     PLoS One. 2021;16:e0252726.
     PubMed     Abstract available
     
     
     
132. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
     Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
     PLoS One. 2021;16:e0254887.
     PubMed     Abstract available
     
     
     
133. ROSENSTROM S, Risom SS, Ejlertsen C, Hove JD, et al
     Dancing with atrial fibrillation - How arrhythmia affects everyday life of family members: A qualitative study.
     PLoS One. 2021;16:e0254130.
     PubMed     Abstract available
     
     
     
134. LIU XH, Xu Q, Luo T, Zhang L, et al
     Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: A systematic review and meta-analysis of prospective studies.
     PLoS One. 2021;16:e0253709.
     PubMed     Abstract available
     
     
     
135. MALLADI CL, Darden D, Aldaas O, Mylavarapu PS, et al
     Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation.
     PLoS One. 2021;16:e0253266.
     PubMed     Abstract available
     
     
     
136. SLAUGHTER MS, Monreal G, Koenig SC, Giridharan GA, et al
     Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
     PLoS One. 2021;16:e0253299.
     PubMed     Abstract available
     
     
     
137. LEE HJ, Kim HK, Kim BS, Han KD, et al
     Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
     PLoS One. 2021;16:e0253310.
     PubMed     Abstract available
     
     
     
138. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
     Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
     PLoS One. 2021;16:e0253332.
     PubMed     Abstract available
     
     
     
139. HAMMER KP, Mustroph J, Stauber T, Birchmeier W, et al
     Beneficial effect of voluntary physical exercise in Plakophilin2 transgenic mice.
     PLoS One. 2021;16:e0252649.
     PubMed     Abstract available
     
     
     
140. MISGANAW A, Sitote M, Jemal S, Melese E, et al
     Comparison of intravenous magnesium sulphate and lidocaine for attenuation of cardiovascular response to laryngoscopy and endotracheal intubation in elective surgical patients at Zewditu Memorial Hospital Addis Ababa, Ethiopia.
     PLoS One. 2021;16:e0252465.
     PubMed     Abstract available
     
     
     
141. PALACIO LC, Pachajoa DC, Durango-Giraldo G, Zapata-Hernandez C, et al
     Atrial proarrhythmic effect of lead as one of the PM10 metal components of air pollution. An in-silico study.
     PLoS One. 2021;16:e0258313.
     PubMed     Abstract available
     
     
     
142. KIM BJ, Lee KJ, Park EL, Tanaka K, et al
     Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.
     PLoS One. 2021;16:e0258377.
     PubMed     Abstract available
     
     
     
143. LANGE M, Hirahara AM, Ranjan R, Stoddard GJ, et al
     Atrial slow conduction develops and dynamically expands during premature stimulation in an animal model of persistent atrial fibrillation.
     PLoS One. 2021;16:e0258285.
     PubMed     Abstract available
     
     
     
144. STEINHUBL SR, Waalen J, Sanyal A, Edwards AM, et al
     Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
     PLoS One. 2021;16:e0258276.
     PubMed     Abstract available
     
     
     
145. NIJPELS G, van der Heijden AAWA, Elders P, Beulens JWJ, et al
     The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes.
     PLoS One. 2021;16:e0255466.
     PubMed     Abstract available
     
     
     
146. CHO JH, Leong D, Cuk N, Ebinger JE, et al
     Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
     PLoS One. 2021;16:e0254641.
     PubMed     Abstract available
     
     
     
147. GARCIA-VILLAFRANCA A, Barrera-Lopez L, Pose-Bar M, Pardellas-Santiago E, et al
     De-novo non-convulsive status epilepticus in adult medical inpatients without known epilepsy: Analysis of mortality related factors and literature review.
     PLoS One. 2021;16:e0258602.
     PubMed     Abstract available
     
     
     
148. PIAYDA K, Afzal S, Nielsen-Kudsk JE, Schmidt B, et al
     Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study.
     PLoS One. 2021;16:e0255721.
     PubMed     Abstract available
     
     
     
149. RIVOLO S, Di Fusco M, Polanco C, Kang A, et al
     Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.
     PLoS One. 2021;16:e0259251.
     PubMed     Abstract available
     
     
     
150. QIAN Y, Zhang J, Li J, Weng Z, et al
     A retrospective study on the evaluation of the appropriateness of oral anticoagulant therapy for patients with atrial fibrillation.
     PLoS One. 2021;16:e0259199.
     PubMed     Abstract available
     
     
     
151. NEUBER JU, Pakhomov AG, Zemlin CW
     Electroporation safety factor of 300 nanosecond and 10 millisecond defibrillation in Langendorff-perfused rabbit hearts.
     PLoS One. 2021;16:e0257287.
     PubMed     Abstract available
     
     
     
152. CANNAVAN PMS, Cannavan FPS, Oliveira HC, Walfridsson U, et al
     A Brazilian Portuguese translation, cultural adaptation and validation of the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) health-related quality of life (HRQOL) scale.
     PLoS One. 2021;16:e0256851.
     PubMed     Abstract available
     
     
     
153. XIAO J, Zhang Y, Tang Y, Dai H, et al
     MiRNA-1202 promotes the TGF-beta1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS.
     PLoS One. 2021;16:e0256066.
     PubMed     Abstract available
     
     
     
154. REINHARDT SW, Desai NR, Tang Y, Jones PG, et al
     Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial.
     PLoS One. 2021;16:e0256338.
     PubMed     Abstract available
     
     
     
155. LANKESTER J, Zanetti D, Ingelsson E, Assimes TL, et al
     Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study.
     PLoS One. 2021;16:e0255801.
     PubMed     Abstract available
     
     
     
156. KIM IS, Choi YJ, Choi EY, Min PK, et al
     Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
     PLoS One. 2021;16:e0258770.
     PubMed     Abstract available
     
     
     
157. BAHRAMI RAD A, Galloway C, Treiman D, Xue J, et al
     Atrial fibrillation detection in outpatient electrocardiogram monitoring: An algorithmic crowdsourcing approach.
     PLoS One. 2021;16:e0259916.
     PubMed     Abstract available
     
     
     
158. NAM KW, Kwon HM, Lee YS
     Effects of intracranial atherosclerosis and atrial fibrillation on the prognosis of ischemic stroke with active cancer.
     PLoS One. 2021;16:e0259627.
     PubMed     Abstract available
     
     
     
159. WATANABE K, Nagata Y, Nitta G, Okata S, et al
     Impact of the sinus node recovery time after termination of atrial fibrillation during catheter ablation on clinical outcomes in patients with persistent atrial fibrillation.
     PLoS One. 2021;16:e0259750.
     PubMed     Abstract available
     
     
     
160. YANAGISAWA D, Abe K, Amano H, Komatsuda S, et al
     Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
     PLoS One. 2021;16:e0260585.
     PubMed     Abstract available
     
     
     
161. STRUPPEK J, Schnabel RB, Walther C, Heydecke G, et al
     Periodontitis, dental plaque, and atrial fibrillation in the Hamburg City Health Study.
     PLoS One. 2021;16:e0259652.
     PubMed     Abstract available
     
     
     
162. MOTOC A, Luchian ML, Scheirlynck E, Roosens B, et al
     Incremental value of left atrial strain to predict atrial fibrillation recurrence after cryoballoon ablation.
     PLoS One. 2021;16:e0259999.
     PubMed     Abstract available
     
     
     
163. SUBA S, Fleischmann KE, Schell-Chaple H, Prasad P, et al
     Diagnostic and prognostic significance of premature ventricular complexes in community and hospital-based participants: A scoping review.
     PLoS One. 2021;16:e0261712.
     PubMed     Abstract available
     
     
     
164. SAGER S, Bernhardt F, Kehrle F, Merkert M, et al
     Expert-enhanced machine learning for cardiac arrhythmia classification.
     PLoS One. 2021;16:e0261571.
     PubMed     Abstract available
     
     
     
165. YOSHIKAWA M, Asaba K, Nakayama T
     Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study.
     PLoS One. 2021;16:e0261020.
     PubMed     Abstract available
     
     
     
166. LIU HT, Yang CH, Lee HL, Chang PC, et al
     Clinical Outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients.
     PLoS One. 2021;16:e0260834.
     PubMed     Abstract available
     
     
     
167. JANG JH, Kim TY, Lim HS, Yoon D, et al
     Unsupervised feature learning for electrocardiogram data using the convolutional variational autoencoder.
     PLoS One. 2021;16:e0260612.
     PubMed     Abstract available
     
     
     
168. PATON MF, Gierula J, Lowry JE, Cairns DA, et al
     Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial.
     PLoS One. 2021;16:e0259450.
     PubMed     Abstract available
     
     
     
169. ANDERSON K, Bavishi C, Kolte D, Gohh R, et al
     Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation.
     PLoS One. 2021;16:e0260718.
     PubMed     Abstract available
     
     
     
170. KUFNER A, Ali HF, Ebinger M, Fiebach JB, et al
     The smoking paradox in ischemic stroke patients treated with intra-arterial thrombolysis in combination with mechanical thrombectomy-VISTA-Endovascular.
     PLoS One. 2021;16:e0251888.
     PubMed     Abstract available
     
     
     
171. IKEDA T, Ogawa S, Kitazono T, Nakagawara J, et al
     Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.
     PLoS One. 2021;16:e0251325.
     PubMed     Abstract available
     
     
     
172. SU MI, Liu CW
     Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia.
     PLoS One. 2021;16:e0252030.
     PubMed     Abstract available
     
     
     
173. LO CH, Wang YH, Tsai CF, Chan KC, et al
     Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.
     PLoS One. 2021;16:e0251918.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: